Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in preand postmenopausal women

被引:47
作者
Talley, LI
Grizzle, WE
Waterbor, JW
Brown, D
Weiss, H
Frost, AR
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Ctr Comprehens Canc, Biostat Unit, Birmingham, AL 35233 USA
关键词
breast cancer; menopause; age; estrogen receptors; progesterone receptors; proliferation; p27(Kip1);
D O I
10.1002/ijc.10171
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancers in younger, premenopausal women are more likely to exhibit an adverse prognostic profile (including negative steroid hormone receptors and a high rate of cellular proliferation) and poor outcome than breast cancers in postmenopausal women. It has been hypothesized that this adverse prognostic profile is a result of the higher histologic grade of breast cancers in pre- compared with post-menopausal women. To assess the association of expression of steroid hormone receptors and indicators of proliferation while controlling for histologic grade, we identified 100 infiltrating ductal carcinomas from premenopausal women 45 years of age or younger and 100 from postmenopausal women 65 years of age or older. The carcinomas were selected so that the histologic grades (low versus high) were distributed equally between the 2 groups. Estrogen receptors (ER), progesterone receptors (PR), p27(Kip1) and Ki-67 (to measure rate of proliferation) were assessed by immunohistochernistry and compared between groups. Clinical information and survival data were also analyzed. ER content was lower and proliferation was higher in carcinomas in premenopausal women (p = 0.048 and p = 0.005, respectively). By univariate analysis, p27(Kip1) and PR were not different between the groups; however, in multivariate analysis, p27(Kip1) was higher in postmenopausal women, but only in a subgroup with highly proliferative carcinomas. Overall survival was similar in the pre- and postmenopausal women. Furthermore, low p27(Kip1) and African-American ethnicity predicted a poorer overall survival in the premenopausal, but not in the postmenopausal, women in our study. After controlling for histologic grade, a lower expression of ER and a higher proliferative index were detected in breast carcinomas in premenopausal women. Therefore, some prognostic indicators, such as ER and proliferative rate, may be more closely associated with menopausal status than histologic grade. Our data also suggest that some prognostic factors are not equally effective as predictors of survival in pre- and postmenopausal women. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:118 / 127
页数:10
相关论文
共 130 条
[1]   Hormonal profiles and estrogen receptors in Egyptian female breast cancer patients [J].
Abu-Bedair, FA ;
El-Gamal, BA ;
Ibrahim, NA ;
El-Aaser, AA .
TUMORI JOURNAL, 2000, 86 (01) :24-29
[2]   THE RELATION BETWEEN SURVIVAL AND AGE AT DIAGNOSIS IN BREAST-CANCER [J].
ADAMI, HO ;
MALKER, B ;
HOLMBERG, L ;
PERSSON, I ;
STONE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09) :559-563
[3]   Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? [J].
Aebi, S ;
Gelber, S ;
Castiglione-Gertsch, M ;
Gelber, RD ;
Collins, J ;
Thürlimann, B ;
Rudenstam, CM ;
Lindtner, J ;
Crivellari, D ;
Cortes-Funes, H ;
Simoncini, E ;
Werner, ID ;
Coates, AS ;
Goldhirsch, A .
LANCET, 2000, 355 (9218) :1869-1874
[4]  
Albain K S, 1994, J Natl Cancer Inst Monogr, P35
[5]   PROPORTIONAL HAZARDS AND RECURSIVE PARTITIONING AND AMALGAMATION ANALYSES OF THE SOUTHWEST ONCOLOGY GROUP NODE-POSITIVE ADJUVANT CMFVP BREAST-CANCER DATA-BASE - A PILOT-STUDY [J].
ALBAIN, KS ;
GREEN, S ;
LEBLANC, M ;
RIVKIN, S ;
OSULLIVAN, J ;
OSBORNE, CK .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :273-284
[6]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[7]  
[Anonymous], J WALKERS METHODS MO
[8]  
Barbareschi M, 2000, INT J CANCER, V89, P236, DOI 10.1002/1097-0215(20000520)89:3<236::AID-IJC5>3.3.CO
[9]  
2-Q
[10]   Perturbations of the hypothalamic-pituitary-adrenal axis and the Metabolic Syndrome in ageing [J].
Björntorp, P ;
Rosmond, R .
GROWTH HORMONE & IGF RESEARCH, 1999, 9 :121-123